Evidence map›Paper›PMID 37448706›Full record

ArticleTobacco prevention & cessation2023

Good Practice Statements for the treatment of nicotine dependence.

Renata Solimini, Otto Ruokolainen, Zsuzsa Cselko, Helena Koprivnikar, Lorenzo Spizzichino, Stathis Papachristou, Adrián González-Marrón, Emilia Nunes, Dolors Carnicer-Pont, Esteve Fernandez and 8 more

Abstract readEditorial
In one paragraph

Article in Tobacco prevention & cessation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Renata SoliminiIstituto Superiore di Sanita, National Centre on Addiction and Doping, Rome, Italy.
Otto RuokolainenFinnish Institute for Health and Welfare, Helsinki, Finland.
Zsuzsa CselkoNational Koranyi Institute of Pulmonology, Budapest, Hungary.
Helena KoprivnikarNational Institute of Public Health, Slovenia.
Lorenzo SpizzichinoMinistry of Health - Prevention Department, Rome, Italy.
Stathis PapachristouNational Public Health Organization, Athens, Greece.
Adrián González-MarrónGroup of Evaluation of Health Determinants and Health Policies, Department of Basic Sciences, Universitat Internacional de Catalunya, Sant Cugat del Valles, Spain.
Emilia NunesNational Programme for Smoking Prevention and Tobacco Control, General-Directorate of Health, Portugal.
Dolors Carnicer-PontTobacco Control Unit and WHO Collaborating Center for Tobacco Control, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Spain.
Esteve FernandezTobacco Control Unit and WHO Collaborating Center for Tobacco Control, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Spain.
Anna Mar LópezTobacco Control Unit and WHO Collaborating Center for Tobacco Control, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Spain.
Elena DemosthenousPolicy Department of the Cyprus National Addictions Authority, Nicosia, Cyprus.
Biljana KilibardaInstitute of Public Health of Serbia "Dr Milan Jovanović Batut", Belgrade, Serbia.
Silvano GallusIstituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Cristina Gómez-ChacónMinisterio de Sanidad, Madrid, Spain.
Ivona KećCroatian Institute of Public Health, Zagreb, Croatia.
Maja ValenticCroatian Institute of Public Health, Zagreb, Croatia.
Hanna OllilaFinnish Institute for Health and Welfare, Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

good practice statementsnew and emerging productsnicotine cessationnicotine dependence

Identifiers

PMID37448706
PMCPMC10336859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.